Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Anticoagulant Activity of Sulfated Ulvan Isolated from the Green Macroalga Ulva rigida.

Adrien A, Bonnet A, Dufour D, Baudouin S, Maugard T, Bridiau N.

Mar Drugs. 2019 May 14;17(5). pii: E291. doi: 10.3390/md17050291.

2.

FLT3 ligand plasma levels have no impact on outcomes after allotransplant in acute leukemia.

Peterlin P, Gaschet J, Guillaume T, Garnier A, Eveillard M, Le Bourgeois A, Cherel M, Debord C, Le Bris Y, Theisen O, Mahé B, Dubruille V, Godon C, Robillard N, Wuilleme S, Touzeau C, Gastinne T, Blin N, Lok A, Bonnet A, Le Gouill S, Moreau P, Béné MC, Chevallier P.

Cytokine. 2019 Aug;120:85-87. doi: 10.1016/j.cyto.2019.04.015. Epub 2019 Apr 28.

PMID:
31035172
3.

Influence of Donor Type (Sibling versus Matched Unrelated Donor versus Haploidentical Donor) on Outcomes after Clofarabine-Based Reduced-Intensity Conditioning Allograft for Myeloid Malignancies.

Bouard L, Guillaume T, Peterlin P, Garnier A, Le Bourgeois A, Duquenne A, Mahe B, Dubruille V, Blin N, Touzeau C, Gastinne T, Le Bris Y, Lok A, Bonnet A, Le Gouill S, Moreau P, Bene MC, Chevallier P.

Biol Blood Marrow Transplant. 2019 Mar 27. pii: S1083-8791(19)30209-5. doi: 10.1016/j.bbmt.2019.03.025. [Epub ahead of print]

PMID:
30928627
4.

Pomalidomide, cyclophosphamide, and dexamethasone for relapsed/refractory multiple myeloma patients in a real-life setting: a single-center retrospective study.

Trudel S, Tessoulin B, Jullien M, Blin N, Gastinne T, Mahé B, Dubruille V, Bonnet A, Lok A, Chevallier P, Peterlin P, Garnier A, Guillaume T, Le Bourgeois A, Le Gouill S, Moreau P, Touzeau C.

Ann Hematol. 2019 Jun;98(6):1441-1447. doi: 10.1007/s00277-019-03649-3. Epub 2019 Mar 14.

PMID:
30874851
5.

Single-agent daratumumab in very advanced relapsed and refractory multiple myeloma patients: a real-life single-center retrospective study.

Jullien M, Trudel S, Tessoulin B, Mahé B, Dubruille V, Blin N, Gastinne T, Bonnet A, Lok A, Lebourgeois A, Peterlin P, Garnier A, Chevalier P, Guillaume T, Thomaré P, Le Gouill S, Moreau P, Touzeau C.

Ann Hematol. 2019 Jun;98(6):1435-1440. doi: 10.1007/s00277-019-03655-5. Epub 2019 Mar 14.

PMID:
30874850
6.

Bixin, an apocarotenoid isolated from Bixa orellana L., sensitizes human melanoma cells to dacarbazine-induced apoptosis through ROS-mediated cytotoxicity.

de Oliveira Júnior RG, Bonnet A, Braconnier E, Groult H, Prunier G, Beaugeard L, Grougnet R, da Silva Almeida JRG, Ferraz CAA, Picot L.

Food Chem Toxicol. 2019 Mar;125:549-561. doi: 10.1016/j.fct.2019.02.013. Epub 2019 Feb 7.

PMID:
30738990
7.

FLT3 ligand plasma levels in acute myeloid leukemia.

Peterlin P, Gaschet J, Guillaume T, Garnier A, Eveillard M, Le Bourgeois A, Cherel M, Debord C, Le Bris Y, Theisen O, Mahé B, Dubruille V, Godon C, Robillard N, Wuilleme S, Touzeau C, Gastinne T, Blin N, Lok A, Bonnet A, Le Gouill S, Moreau P, Béné MC, Chevallier P.

Haematologica. 2019 Jun;104(6):e240-e243. doi: 10.3324/haematol.2018.209460. Epub 2019 Jan 10. No abstract available.

8.

Deauville Scores 4 or 5 Assessed by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Early Post-Allotransplant Is Highly Predictive of Relapse in Lymphoma Patients.

Bouard L, Bodet-Milin C, Bailly C, Guillaume T, Peterlin P, Garnier A, Bourgeois AL, Mahé B, Dubruille V, Blin N, Touzeau C, Gastinne T, Lok A, Bonnet A, Béné MC, Gouill SL, Moreau P, Kraeber-Bodéré F, Chevallier P.

Biol Blood Marrow Transplant. 2019 May;25(5):906-911. doi: 10.1016/j.bbmt.2018.11.019. Epub 2018 Nov 24.

PMID:
30481598
9.

Metabolomics based on UHPLC-QToF- and APGC-QToF-MS reveals metabolic pathways reprogramming in response to tidal cycles in the sub-littoral species Mimachlamys varia exposed to aerial emergence.

Ory P, Bonnet A, Mondeguer F, Breitwieser M, Dubillot E, Graber M.

Comp Biochem Physiol Part D Genomics Proteomics. 2019 Mar;29:74-85. doi: 10.1016/j.cbd.2018.11.002. Epub 2018 Nov 8.

PMID:
30458431
10.

BH3-mimetic toolkit guides the respective use of BCL2 and MCL1 BH3-mimetics in myeloma treatment.

Gomez-Bougie P, Maiga S, Tessoulin B, Bourcier J, Bonnet A, Rodriguez MS, Le Gouill S, Touzeau C, Moreau P, Pellat-Deceunynck C, Amiot M.

Blood. 2018 Dec 20;132(25):2656-2669. doi: 10.1182/blood-2018-03-836718. Epub 2018 Oct 11.

11.

Synthesis of 2-Mercapto-(2-Oxoindolin-3-Ylidene)Acetonitriles from 3-(4-Chloro-5H-1,2,3-Dithiazol-5-Ylidene)Indolin-2-ones.

Letribot B, Delatouche R, Rouillard H, Bonnet A, Chérouvrier JR, Domon L, Besson T, Thiéry V.

Molecules. 2018 Jun 8;23(6). pii: E1390. doi: 10.3390/molecules23061390.

12.

Post-treatment positron emission tomography-computed tomography is highly predictive of outcome in Plasmablastic lymphoma.

Al Tabaa Y, Tchernonog E, Faurie P, Cottereau AS, Monjanel H, Bonnet A, Le Gouill S, Gyan E, Ghesquieres H, Mariano-Goulart D, Cartron G.

Eur J Nucl Med Mol Imaging. 2018 Sep;45(10):1705-1709. doi: 10.1007/s00259-018-4020-5. Epub 2018 Apr 20.

PMID:
29679112
13.

Safety of ixazomib for the treatment of multiple myeloma.

Bonnet A, Moreau P.

Expert Opin Drug Saf. 2017 Aug;16(8):973-980. doi: 10.1080/14740338.2017.1344212. Epub 2017 Jul 12. Review.

PMID:
28661711
14.

Identification of ace inhibitory cryptides in Tilapia protein hydrolysate by UPLC-MS/MS coupled to database analysis.

Yesmine BH, Antoine B, da Silva Ortência Leocádia NG, Rogério BW, Ingrid A, Nicolas B, Thierry M, Jean-Marie P, Frédéric S, Stéphanie BJ.

J Chromatogr B Analyt Technol Biomed Life Sci. 2017 May 1;1052:43-50. doi: 10.1016/j.jchromb.2017.02.015. Epub 2017 Feb 14.

PMID:
28351802
15.

Pilot production of ulvans from Ulva sp. and their effects on hyaluronan and collagen production in cultured dermal fibroblasts.

Adrien A, Bonnet A, Dufour D, Baudouin S, Maugard T, Bridiau N.

Carbohydr Polym. 2017 Feb 10;157:1306-1314. doi: 10.1016/j.carbpol.2016.11.014. Epub 2016 Nov 4.

PMID:
27987837
16.

Improved racemate resolution of pentan-2-ol and trans-(Z)-cyclooct-5-ene-1,2-diol by lipase catalysis.

Graber M, Rouillard H, Delatouche R, Fniter N, Belkhiria B, Bonnet A, Domon L, Thiéry V.

J Biotechnol. 2016 Nov 20;238:60-68. doi: 10.1016/j.jbiotec.2016.09.010. Epub 2016 Sep 23.

PMID:
27671695
17.

Successful treatment of acute promyelocytic leukemia with arsenic trioxide and all-trans retinoic acid in a double lung and kidney transplanted patient.

Peterlin P, Garnier A, Tissot A, Garandeau C, Houreau-Langlard D, Hourmant M, Vantyghem S, Bonnet A, Guillaume T, Béné MC, Le Gouill S, Moreau P, Chevallier P.

Ann Hematol. 2016 Oct;95(10):1737-8. doi: 10.1007/s00277-016-2754-3. Epub 2016 Jul 27. No abstract available.

PMID:
27465153
18.

UPLC-MSE profiling of Phytoplankton metabolites: application to the identification of pigments and structural analysis of metabolites in Porphyridium purpureum.

Juin C, Bonnet A, Nicolau E, Bérard JB, Devillers R, Thiéry V, Cadoret JP, Picot L.

Mar Drugs. 2015 Apr 22;13(4):2541-58. doi: 10.3390/md13042541.

19.

Characterization of the colistin (polymyxin E1 and E2) biosynthetic gene cluster.

Tambadou F, Caradec T, Gagez AL, Bonnet A, Sopéna V, Bridiau N, Thiéry V, Didelot S, Barthélémy C, Chevrot R.

Arch Microbiol. 2015 May;197(4):521-32. doi: 10.1007/s00203-015-1084-5. Epub 2015 Jan 22.

PMID:
25609230
20.

Subcutaneous bortezomib incorporated into the bortezomib-thalidomide-dexamethasone regimen as part of front-line therapy in the context of autologous stem cell transplantation for multiple myeloma.

Lok A, Mocquard J, Bourcier J, Redelsperger L, Bonnet A, Chauvin C, Thomaré P, Mahé B, Touzeau C, Moreau P.

Haematologica. 2014 Mar;99(3):e33-4. doi: 10.3324/haematol.2013.100396. Epub 2014 Feb 14. No abstract available.

Supplemental Content

Loading ...
Support Center